InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Marucci Anthony S, Chairman & CEO. Director active across 1 company, notably Celldex Therapeutics, Inc.. Cumulatively, 4 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €288k. History available since 5 August 2021. The latest transaction was filed on 11 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
11,500 shares@ US$26.8238.7% of flowCommon StockSEC:0001415889-24-026489:0
Ideal exit: 8 Aug 2025 (T+270)
75,000 shares@ US$2.7827.6% of flowCommon StockSEC:0001415889-22-008769:0
3,537 shares@ US$42.000.0051% mcap50.0% of flowCommon StockSEC:0001179110-21-008010:0
3,537 shares@ US$42.0016.9% of flowCommon StockSEC:0001179110-21-008010
4 of 4 declarations
About Marucci Anthony S
Anthony S. Marucci is the President & CEO at Celldex Therapeutics, Inc. He leads the company and is responsible for overall strategy and operations. Anthony plays a vital role in developing new treatments and achieving the company's objectives.
